Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

781428

	registered interest
	date	31/10/2017
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	UK Visas and Immigration: Lost Property
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, pursuant to the Answer of 17 October 2017 to Question 105855, what information her Department holds on the number of people who have registered complaints for the loss of documents by UK Visas and Immigration in each of the last seven years.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	110694
	answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>The following information is available at <a href="https://www.gov.uk/government/collections/migration-transparency-data" target="_blank">https://www.gov.uk/government/collections/migration-transparency-data</a></p> answering member constituency Great Yarmouth answering member printed Brandon Lewis question first answered 07/11/2017 16:14:11 answering member 4009 label Biography information for Sir Brandon Lewis
	tabling member	4430 label Biography information for Alison Thewliss

782859

	registered interest
	date	02/11/2017
	answering body	Northern Ireland Office
	answering dept id	21
	answering dept short name	Northern Ireland
	answering dept sort name	Northern Ireland
	hansard heading	Northern Ireland Office: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Northern Ireland, when he plans to respond to the letter of 4 July 2017 from the British Association of Social Workers on universal credit specific circumstances and the Criminal Law Act (Northern Ireland) 1967.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	111057
	answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>A response to the British Association of Social Workers will issue this week.</p> answering member constituency Norwich North answering member printed Chloe Smith question first answered 07/11/2017 10:44:40 answering member 1609 label Biography information for Chloe Smith
	tabling member	4430 label Biography information for Alison Thewliss

788559

	registered interest
	date	13/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to ensure access to cross-border clinical trial data after the UK leaves the EU.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	112739
	answer	answer is ministerial correction date of answer 16/11/2017 answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of Exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU.</p><p> </p><p>On 3 November, the Government published its response to the Accelerated Access Review. It set out plans to give patients quicker access to life-changing treatments; and, make the United Kingdom the best place in the world for industry to invest and innovate. From April 2018, the new Accelerated Access Pathway will mean selected products with the greatest potential to change lives could be available up to four years earlier by reducing the time taken to negotiate the evaluation and financial approvals necessary before the National Health Service can purchase them.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and NHS have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p><p> </p><p>The UK anticipates continuing to work with EU partners on sharing of clinical data across borders where applicable under legal frameworks and with the consent of the data subject. While we cannot pre-empt the outcome of the negotiations on the UK’s exit from the EU, our aim will be to ensure that patients continue to access the best and most innovative medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 112740 112741 question first answered 16/11/2017 12:10:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4430 label Biography information for Alison Thewliss

788560

	registered interest
	date	13/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he has taken to prepare for the implementation of the EU Clinical Trials Regulation in 2019.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	112740
	answer	answer is ministerial correction date of answer 16/11/2017 answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of Exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU.</p><p> </p><p>On 3 November, the Government published its response to the Accelerated Access Review. It set out plans to give patients quicker access to life-changing treatments; and, make the United Kingdom the best place in the world for industry to invest and innovate. From April 2018, the new Accelerated Access Pathway will mean selected products with the greatest potential to change lives could be available up to four years earlier by reducing the time taken to negotiate the evaluation and financial approvals necessary before the National Health Service can purchase them.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and NHS have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p><p> </p><p>The UK anticipates continuing to work with EU partners on sharing of clinical data across borders where applicable under legal frameworks and with the consent of the data subject. While we cannot pre-empt the outcome of the negotiations on the UK’s exit from the EU, our aim will be to ensure that patients continue to access the best and most innovative medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 112739 112741 question first answered 16/11/2017 12:10:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4430 label Biography information for Alison Thewliss

788561

	registered interest
	date	13/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to maintain access to new medicines from clinical trials after the UK leaves the EU.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	112741
	answer	answer is ministerial correction date of answer 16/11/2017 answer text <p>The Government values the strong collaborative partnerships that we have across the European Union in the areas of science, research and innovation, and as part of Exit negotiations is working to ensure that we have the best possible environment in which to support clinical trials and new medicines after we leave the EU.</p><p> </p><p>On 3 November, the Government published its response to the Accelerated Access Review. It set out plans to give patients quicker access to life-changing treatments; and, make the United Kingdom the best place in the world for industry to invest and innovate. From April 2018, the new Accelerated Access Pathway will mean selected products with the greatest potential to change lives could be available up to four years earlier by reducing the time taken to negotiate the evaluation and financial approvals necessary before the National Health Service can purchase them.</p><p> </p><p>In the UK, the Medicines and Healthcare products Regulatory Agency, Health Research Authority, ethics services, National Institute for Health Research and NHS have been working towards implementation of the new European Clinical Trials Regulation (CTR) since it was agreed in 2014. The application date of the CTR across the EU will be set by the European Commission. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p><p> </p><p>The UK anticipates continuing to work with EU partners on sharing of clinical data across borders where applicable under legal frameworks and with the consent of the data subject. While we cannot pre-empt the outcome of the negotiations on the UK’s exit from the EU, our aim will be to ensure that patients continue to access the best and most innovative medicines.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 112739 112740 question first answered 16/11/2017 12:10:11 answering member 4067 label Biography information for Steve Brine
	tabling member	4430 label Biography information for Alison Thewliss

793154

	registered interest
	date	21/11/2017
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Visas: New Businesses
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, how many Tier 1 (Entrepreneur) visa applications were refused in 2016-17 as a result of applicants being unable to provide evidence of investment funds in regulated financial institutions.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	114939
	answer	answer is ministerial correction date of answer 23/11/2017 answer text <p>The Home Office retains records of visa decisions, including reasons for refusal, on internal casework systems. This information is not collated in central statistical databases, and is not recorded in a format suitable for publication.</p><p> </p><p>It is an integral feature of the Tier 1 (Entrepreneur) route that all applicants provide the required evidence to show that they hold the required minimum funds to invest in their business.</p> answering member constituency Great Yarmouth answering member printed Brandon Lewis question first answered 23/11/2017 17:39:10 answering member 4009 label Biography information for Sir Brandon Lewis
	tabling member	4430 label Biography information for Alison Thewliss

793157

	registered interest
	date	21/11/2017
	answering body	Cabinet Office
	answering dept id	53
	answering dept short name	Cabinet Office
	answering dept sort name	Cabinet Office
	hansard heading	Older People: Glasgow Central
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Minister for the Cabinet Office, how many (a) women and (b) men attained the age of 100 in Glasgow Central constituency in each year since 2005.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	114942
	answer	answer is ministerial correction date of answer 30/11/2017 answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 30/11/2017 11:16:14 answering member 4021 label Biography information for Chris Skidmore attachment 1 file name PQ114942.pdf title UKSA response
	tabling member	4430 label Biography information for Alison Thewliss

797429

	registered interest
	date	29/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Breast Milk: Donors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will produce guidelines to regulate the sharing of human breast milk.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	116392
	answer	answer is ministerial correction date of answer 04/12/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced a guideline on the safe operation of milk banks. This was published in 2010, reviewed in 2014 and is next due for review in 2019. The guideline covers how donor milk banks should recruit, screen and support women who donate breast milk. It also covers how milk banks should handle and process the breast milk they receive from donors. This is available at:</p><p><a href="https://www.nice.org.uk/guidance/CG93" target="_blank">https://www.nice.org.uk/guidance/CG93</a></p><p>There are no plans to change the way milk banks are funded, which is through a mix of National Health Service funding and public donations.</p><p> </p><p>There is already a network of 16 milk banks across the United Kingdom (14 are in England, with one each in Northern Ireland and one in Scotland). Further information is available on the website of the UK Association for Milk Banking at:</p><p><a href="http://www.ukamb.org/milk-banks/" target="_blank">http://www.ukamb.org/milk-banks/</a></p><p>No assessment has been made of the adequacy of human milk bank provision across the UK. Local initiatives are underway to maximise provision – for example, milk banks in Glasgow and Oxford are piloting the use of a novel traffic light system so that the babies at most need are prioritised when milk stocks run low. Also, the NICE guideline includes recommendations that have led to improvements in how milk banks operate. Revised criteria for the microbiological acceptance of donor breast milk have led to higher volumes being available due to lower discard rates.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 116394 116397 116402 question first answered 04/12/2017 17:26:07 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4430 label Biography information for Alison Thewliss

797431

	registered interest
	date	29/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Breast Milk: Donors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans he has to fund human milk banks.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	116394
	answer	answer is ministerial correction date of answer 04/12/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced a guideline on the safe operation of milk banks. This was published in 2010, reviewed in 2014 and is next due for review in 2019. The guideline covers how donor milk banks should recruit, screen and support women who donate breast milk. It also covers how milk banks should handle and process the breast milk they receive from donors. This is available at:</p><p><a href="https://www.nice.org.uk/guidance/CG93" target="_blank">https://www.nice.org.uk/guidance/CG93</a></p><p>There are no plans to change the way milk banks are funded, which is through a mix of National Health Service funding and public donations.</p><p> </p><p>There is already a network of 16 milk banks across the United Kingdom (14 are in England, with one each in Northern Ireland and one in Scotland). Further information is available on the website of the UK Association for Milk Banking at:</p><p><a href="http://www.ukamb.org/milk-banks/" target="_blank">http://www.ukamb.org/milk-banks/</a></p><p>No assessment has been made of the adequacy of human milk bank provision across the UK. Local initiatives are underway to maximise provision – for example, milk banks in Glasgow and Oxford are piloting the use of a novel traffic light system so that the babies at most need are prioritised when milk stocks run low. Also, the NICE guideline includes recommendations that have led to improvements in how milk banks operate. Revised criteria for the microbiological acceptance of donor breast milk have led to higher volumes being available due to lower discard rates.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 116392 116397 116402 question first answered 04/12/2017 17:26:07 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4430 label Biography information for Alison Thewliss

797434

	registered interest
	date	29/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Breast Milk: Donors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what consideration he has given to establishing a network of human milk banks.
	tabling member constituency	Glasgow Central
	tabling member printed	Alison Thewliss
	uin	116397
	answer	answer is ministerial correction date of answer 04/12/2017 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced a guideline on the safe operation of milk banks. This was published in 2010, reviewed in 2014 and is next due for review in 2019. The guideline covers how donor milk banks should recruit, screen and support women who donate breast milk. It also covers how milk banks should handle and process the breast milk they receive from donors. This is available at:</p><p><a href="https://www.nice.org.uk/guidance/CG93" target="_blank">https://www.nice.org.uk/guidance/CG93</a></p><p>There are no plans to change the way milk banks are funded, which is through a mix of National Health Service funding and public donations.</p><p> </p><p>There is already a network of 16 milk banks across the United Kingdom (14 are in England, with one each in Northern Ireland and one in Scotland). Further information is available on the website of the UK Association for Milk Banking at:</p><p><a href="http://www.ukamb.org/milk-banks/" target="_blank">http://www.ukamb.org/milk-banks/</a></p><p>No assessment has been made of the adequacy of human milk bank provision across the UK. Local initiatives are underway to maximise provision – for example, milk banks in Glasgow and Oxford are piloting the use of a novel traffic light system so that the babies at most need are prioritised when milk stocks run low. Also, the NICE guideline includes recommendations that have led to improvements in how milk banks operate. Revised criteria for the microbiological acceptance of donor breast milk have led to higher volumes being available due to lower discard rates.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 116392 116394 116402 question first answered 04/12/2017 17:26:07 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	4430 label Biography information for Alison Thewliss